Antibacterials for systemic use | Tenderlake

Antibacterials for systemic use

Contract Value:
-
Notice Type:
Contract Notice
Published Date:
13 October 2020
Closing Date:
10 November 2020
Location(s):
BE211 Arr. Antwerpen (BE Belgium/BELGIQUE-BELGIË)
Description:
Framework agreement for the supply of Anidulafungin-Linezolid-Voriconazole

See II.1.1

Anidulafungin 100mg IV

See II.2.1

Linezolid infusion 600mg / 300ml

See II.2.1

Linezolid orally 600 mg

See II.2.1

Voriconazole oral 50mg, oral 200mg, IV 200mg

See II.2.1

Linezolid oral solution / syrup

See II.2.1

Voriconazole oral solution / syrup

The initial period of this framework agreement is 12 months and will be tacitly renewed up to 6 times with a period of 6 months.

If an extension is not desired, the contracting authority will notify the contractor in writing at the latest before the start of the new period.

The effective start date will be confirmed in the closing letter.

In the event that one or more products mentioned in this file would be part of a procedure according to the law on public contracts during the contract period, the term will end on the date of conclusion of this procedure.

Download full details as .pdf
The Buyer:
Het Ziekenhuisnetwerk Antwerpen (ZNA) vzw
CPV Code(s):
33651100 - Antibacterials for systemic use